Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?

被引:42
作者
Labombarda, Fabien [1 ]
Saloux, Eric [1 ]
Milesi, Guillaume [1 ]
Bienvenu, Boris [2 ]
机构
[1] CHU Caen, Dept Cardiol, Caen, France
[2] CHU Caen, Dept Internal Med, Caen, France
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2017年 / 34卷 / 04期
关键词
circumferential strain; Fabry disease; hypertrophic cardiomyopathy; LEFT-VENTRICULAR HYPERTROPHY; EUROPEAN-SOCIETY; NATURAL-HISTORY; DISEASE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; APPEARANCE; GUIDELINES; DIAGNOSIS;
D O I
10.1111/echo.13496
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and objectives: Cardiac manifestations in Fabry disease are mainly characterized by left ventricular hypertrophy (LVH). The aims of this study were (1) to describe the pattern of regional strain in patients with Fabry disease and (2) to assess whether this pattern may help differentiate patients with Fabry disease from patients with sarcomeric hypertrophic cardiomyopathy (HCM). Methods: Seventy-seven subjects were investigated: patients with Fabry disease (n=37; 57% with LVH), patients with HCM (n=21), and healthy controls (n=19). Global and segmental longitudinal and circumferential strain (CS) analyses were performed by two-dimensional speckle strain imaging. Base-to-apex longitudinal and CS gradient, defined as the peak gradient difference between averaged basal and apical strain, was calculated. Results: Longitudinal strain gradient did not differ between controls and Fabry patients without hypertrophy (respectively: -10 +/- 3.2 vs -8 +/- 4.3, P=.41) or between the HCM group and Fabry patients with hypertrophy (respectively: -7.5 +/- 4.5 vs -9 +/- 4.5, P=.37). The CS gradient was lower in Fabry patients without hypertrophy compared to the controls (respectively: 1 +/- 8 vs 14.2 +/- 9.5, P <.01), and lower in Fabry patients with hypertrophy compared to the HCM group (respectively: 0.5 +/- 8 vs 6 +/- 9, P <.01). Base-to-apex CS gradient was lost in both Fabry groups. Conclusion: Loss of base-to-apex CS gradient may be a specific left ventricular deformation pattern of Fabry cardiomyopathy in patients with and without LVH.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 26 条
  • [1] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy
    Beer, Meinrad
    Weidemann, Frank
    Breunig, Frank
    Knoll, Anita
    Koeppe, Sabrina
    Machann, Wolfram
    Hahn, Dietbert
    Wanner, Christoph
    Strotmann, Jorg
    Sandstede, Jorn
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) : 1515 - 1518
  • [2] Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy
    Chimenti, C
    Pieroni, M
    Morgante, E
    Antuzzi, D
    Russo, A
    Russo, MA
    Maseri, A
    Frustaci, A
    [J]. CIRCULATION, 2004, 110 (09) : 1047 - 1053
  • [3] Delayed-Enhanced Cardiac MRI for Differentiation of Fabry's Disease from Symmetric Hypertrophic Cardiomyopathy
    De Cobelli, Francesco
    Esposito, Antonio
    Belloni, Elena
    Pieroni, Maurizio
    Perseghin, Gianluca
    Chimenti, Cristina
    Frustaci, Andrea
    Del Maschio, Alessandro
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (03) : W97 - W102
  • [4] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
    Elliott, Perry M.
    Anastasakis, Aris
    Borger, Michael A.
    Borggrefe, Martin
    Cecchi, Franco
    Charron, Philippe
    Hagege, Albert Alain
    Lafont, Antoine
    Limongelli, Giuseppe
    Mahrholdt, Heiko
    McKenna, William J.
    Mogensen, Jens
    Nihoyannopoulos, Petros
    Nistri, Stefano
    Pieper, Petronella G.
    Pieske, Burkert
    Rapezzi, Claudio
    Rutten, Frans H.
    Tillmanns, Christoph
    Watkins, Hugh
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (39) : 2733 - +
  • [5] Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry
    Germain, Dominique P.
    Weidemann, Frank
    Abiose, Ademola
    Patel, Manesh R.
    Cizmarik, Marta
    Cole, J. Alexander
    Beitner-Johnson, Dana
    Benistan, Karelle
    Cabrera, Gustavo
    Charrow, Joel
    Kantola, Ilkka
    Linhart, Ales
    Nicholls, Kathy
    Niemann, Markus
    Scott, C. Ronald
    Sims, Katherine
    Waldek, Stephen
    Warnock, David G.
    Strotmann, Joerg
    [J]. GENETICS IN MEDICINE, 2013, 15 (12) : 958 - 965
  • [6] Fabry disease
    Germain, Dominique P.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
  • [7] Systolic Myocardial Mechanics in Patients with Anderson-Fabry Disease with and without Left Ventricular Hypertrophy and in Comparison to Nonobstructive Hypertrophic Cardiomyopathy
    Gruner, Christiane
    Verocai, Flavia
    Carasso, Shemy
    Vannan, Mani A.
    Jamorski, Michael
    Clarke, Joe T. R.
    Care, Melanie
    Iwanochko, Robert M.
    Rakowski, Harry
    [J]. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (07): : 810 - 817
  • [8] Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance
    Koskenvuo, Juha W.
    Engblom, Erik
    Kantola, Ilkka M.
    Hartiala, Jaakko J.
    Saraste, Antti
    Kiviniemi, Tuomas O.
    Mononen, Ilkka
    Saraste, Markku
    [J]. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2009, 29 (03) : 177 - 180
  • [9] The binary endocardial appearance is a poor discriminator of Anderson-Fabry disease from familial hypertrophic cardiomyopathy
    Kounas, Stavros
    Demetrescu, Camelia
    Pantazis, Antonios A.
    Keren, Andre
    Lee, Philip J.
    Hughes, Derralynn
    Mehta, Atul
    Elliott, Perry Mark
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (21) : 2058 - 2061
  • [10] Echocardiographic Assessment of the Cardiac Amyloidoses
    Koyama, Jun
    Ikeda, Shu-ichi
    Ikeda, Uichi
    [J]. CIRCULATION JOURNAL, 2015, 79 (04) : 721 - 734